1. Home
  2. QSI vs SGHT Comparison

QSI vs SGHT Comparison

Compare QSI & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.90

Market Cap

161.8M

Sector

Health Care

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.33

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QSI
SGHT
Founded
2013
2011
Country
United States
United States
Employees
145
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.8M
187.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
QSI
SGHT
Price
$0.90
$4.33
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$1.00
$9.08
AVG Volume (30 Days)
5.0M
367.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
$618.07
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$2.74
52 Week High
$3.10
$9.24

Technical Indicators

Market Signals
Indicator
QSI
SGHT
Relative Strength Index (RSI) 49.48 58.39
Support Level $0.69 $3.30
Resistance Level $1.10 $5.32
Average True Range (ATR) 0.08 0.26
MACD 0.01 0.11
Stochastic Oscillator 42.69 52.55

Price Performance

Historical Comparison
QSI
SGHT

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: